<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DDI-DrugBank.d172">
    <sentence id="DDI-DrugBank.d172.s0" text="General: Significant interactions may occur when celecoxib is administered together with drugs that inhibit P450 2C9.">
        <entity charOffset="49-57" id="DDI-DrugBank.d172.s0.e0" text="celecoxib" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s1" text="Celecoxib metabolism is predominantly mediated via cytochrome P450 2C9 in the liver.">
        <entity charOffset="0-8" id="DDI-DrugBank.d172.s1.e0" text="Celecoxib" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s2" text="Co-administration of celecoxib with drugs that are known to inhibit 2C9 should be done with caution.">
        <entity charOffset="21-29" id="DDI-DrugBank.d172.s2.e0" text="celecoxib" type="drug"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s3" text="In vitro studies indicate that celecoxib is not an inhibitor of cytochrome P450 2C9, 2C19 or 3A4.">
        <entity charOffset="31-39" id="DDI-DrugBank.d172.s3.e0" text="celecoxib" type="drug"/>
    <negationtags>In vitro studies indicate that celecoxib is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; an inhibitor of cytochrome P450 2C9, 2C19 or 3A4. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d172.s4" text="In vitro studies also indicate that celecoxib, although not a substrate, is an inhibitor of cytochrome P450 2D6.">
        <entity charOffset="36-44" id="DDI-DrugBank.d172.s4.e0" text="celecoxib" type="drug"/>
    <negationtags>In vitro studies also indicate that celecoxib, although &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; a substrate, is an inhibitor of cytochrome P450 2D6. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d172.s5" text="Therefore, there is a potential for an in vivo drug interaction with drugs that are metabolized by P450 2D6."/>
    <sentence id="DDI-DrugBank.d172.s6" text="Clinical studies with celecoxib have identified potentially significant interactions with fluconazole and lithium.">
        <entity charOffset="22-30" id="DDI-DrugBank.d172.s6.e0" text="celecoxib" type="drug"/>
        <entity charOffset="90-100" id="DDI-DrugBank.d172.s6.e1" text="fluconazole" type="drug"/>
        <entity charOffset="106-112" id="DDI-DrugBank.d172.s6.e2" text="lithium" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s6.e0" e2="DDI-DrugBank.d172.s6.e1" id="DDI-DrugBank.d172.s6.p0" type="int"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s6.e0" e2="DDI-DrugBank.d172.s6.e2" id="DDI-DrugBank.d172.s6.p1" type="int"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s6.e1" e2="DDI-DrugBank.d172.s6.e2" id="DDI-DrugBank.d172.s6.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s7" text="Experience with nonsteroidal anti-inflammatory drugs (NSAIDs) suggests the potential for interactions with furosemide and ACE inhibitors.">
        <entity charOffset="16-51" id="DDI-DrugBank.d172.s7.e0" text="nonsteroidal anti-inflammatory drugs" type="group"/>
        <entity charOffset="54-59" id="DDI-DrugBank.d172.s7.e1" text="NSAIDs" type="group"/>
        <entity charOffset="107-116" id="DDI-DrugBank.d172.s7.e2" text="furosemide" type="drug"/>
        <entity charOffset="122-135" id="DDI-DrugBank.d172.s7.e3" text="ACE inhibitors" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s7.e0" e2="DDI-DrugBank.d172.s7.e1" id="DDI-DrugBank.d172.s7.p0"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s7.e0" e2="DDI-DrugBank.d172.s7.e2" id="DDI-DrugBank.d172.s7.p1" type="int"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s7.e0" e2="DDI-DrugBank.d172.s7.e3" id="DDI-DrugBank.d172.s7.p2" type="int"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s7.e1" e2="DDI-DrugBank.d172.s7.e2" id="DDI-DrugBank.d172.s7.p3" type="int"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s7.e1" e2="DDI-DrugBank.d172.s7.e3" id="DDI-DrugBank.d172.s7.p4" type="int"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s7.e2" e2="DDI-DrugBank.d172.s7.e3" id="DDI-DrugBank.d172.s7.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s8" text="The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have not been found.">
        <entity charOffset="12-20" id="DDI-DrugBank.d172.s8.e0" text="celecoxib" type="drug"/>
        <entity charOffset="73-81" id="DDI-DrugBank.d172.s8.e1" text="glyburide" type="drug"/>
        <entity charOffset="84-95" id="DDI-DrugBank.d172.s8.e2" text="ketoconazole" type="drug"/>
        <entity charOffset="98-109" id="DDI-DrugBank.d172.s8.e3" text="methotrexate" type="drug"/>
        <entity charOffset="112-120" id="DDI-DrugBank.d172.s8.e4" text="phenytoin" type="drug"/>
        <entity charOffset="123-133" id="DDI-DrugBank.d172.s8.e5" text="tolbutamide" type="drug"/>
        <entity charOffset="140-147" id="DDI-DrugBank.d172.s8.e6" text="warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e0" e2="DDI-DrugBank.d172.s8.e1" id="DDI-DrugBank.d172.s8.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e0" e2="DDI-DrugBank.d172.s8.e2" id="DDI-DrugBank.d172.s8.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e0" e2="DDI-DrugBank.d172.s8.e3" id="DDI-DrugBank.d172.s8.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e0" e2="DDI-DrugBank.d172.s8.e4" id="DDI-DrugBank.d172.s8.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e0" e2="DDI-DrugBank.d172.s8.e5" id="DDI-DrugBank.d172.s8.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e0" e2="DDI-DrugBank.d172.s8.e6" id="DDI-DrugBank.d172.s8.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e1" e2="DDI-DrugBank.d172.s8.e2" id="DDI-DrugBank.d172.s8.p6"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e1" e2="DDI-DrugBank.d172.s8.e3" id="DDI-DrugBank.d172.s8.p7"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e1" e2="DDI-DrugBank.d172.s8.e4" id="DDI-DrugBank.d172.s8.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e1" e2="DDI-DrugBank.d172.s8.e5" id="DDI-DrugBank.d172.s8.p9"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e1" e2="DDI-DrugBank.d172.s8.e6" id="DDI-DrugBank.d172.s8.p10"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e2" e2="DDI-DrugBank.d172.s8.e3" id="DDI-DrugBank.d172.s8.p11"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e2" e2="DDI-DrugBank.d172.s8.e4" id="DDI-DrugBank.d172.s8.p12"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e2" e2="DDI-DrugBank.d172.s8.e5" id="DDI-DrugBank.d172.s8.p13"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e2" e2="DDI-DrugBank.d172.s8.e6" id="DDI-DrugBank.d172.s8.p14"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e3" e2="DDI-DrugBank.d172.s8.e4" id="DDI-DrugBank.d172.s8.p15"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e3" e2="DDI-DrugBank.d172.s8.e5" id="DDI-DrugBank.d172.s8.p16"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e3" e2="DDI-DrugBank.d172.s8.e6" id="DDI-DrugBank.d172.s8.p17"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e4" e2="DDI-DrugBank.d172.s8.e5" id="DDI-DrugBank.d172.s8.p18"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e4" e2="DDI-DrugBank.d172.s8.e6" id="DDI-DrugBank.d172.s8.p19"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s8.e5" e2="DDI-DrugBank.d172.s8.e6" id="DDI-DrugBank.d172.s8.p20"/>
    <negationtags>The effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide, ketoconazole, methotrexate, phenytoin, tolbutamide, and warfarin have been studied in vivo and clinically important interactions have &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; been found. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d172.s9" text="ACE inhibitors: Reports suggest that NSAIDs may diminish the antihypertensive effect of Angiotensin Converting Enzyme (ACE) inhibitors.">
        <entity charOffset="0-13" id="DDI-DrugBank.d172.s9.e0" text="ACE inhibitors" type="group"/>
        <entity charOffset="37-42" id="DDI-DrugBank.d172.s9.e1" text="NSAIDs" type="group"/>
        <entity charOffset="88-133" id="DDI-DrugBank.d172.s9.e2" text="Angiotensin Converting Enzyme (ACE) inhibitors" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s9.e0" e2="DDI-DrugBank.d172.s9.e1" id="DDI-DrugBank.d172.s9.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s9.e0" e2="DDI-DrugBank.d172.s9.e2" id="DDI-DrugBank.d172.s9.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s9.e1" e2="DDI-DrugBank.d172.s9.e2" id="DDI-DrugBank.d172.s9.p2" type="effect"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s10" text="This interaction should be given consideration in patients taking CELEBREX concomitantly with ACE-inhibitors.">
        <entity charOffset="66-73" id="DDI-DrugBank.d172.s10.e0" text="CELEBREX" type="brand"/>
        <entity charOffset="94-107" id="DDI-DrugBank.d172.s10.e1" text="ACE-inhibitors" type="group"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s10.e0" e2="DDI-DrugBank.d172.s10.e1" id="DDI-DrugBank.d172.s10.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s11" text="Furosemide: Clinical studies, as well as post marketing observations, have shown that NSAIDs can reduce the natriuretic effect of furosemide and thiazides in some patients.">
        <entity charOffset="0-9" id="DDI-DrugBank.d172.s11.e0" text="Furosemide" type="drug"/>
        <entity charOffset="86-91" id="DDI-DrugBank.d172.s11.e1" text="NSAIDs" type="group"/>
        <entity charOffset="130-139" id="DDI-DrugBank.d172.s11.e2" text="furosemide" type="drug"/>
        <entity charOffset="145-153" id="DDI-DrugBank.d172.s11.e3" text="thiazides" type="group"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s11.e0" e2="DDI-DrugBank.d172.s11.e1" id="DDI-DrugBank.d172.s11.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s11.e0" e2="DDI-DrugBank.d172.s11.e2" id="DDI-DrugBank.d172.s11.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s11.e0" e2="DDI-DrugBank.d172.s11.e3" id="DDI-DrugBank.d172.s11.p2"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s11.e1" e2="DDI-DrugBank.d172.s11.e2" id="DDI-DrugBank.d172.s11.p3" type="effect"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s11.e1" e2="DDI-DrugBank.d172.s11.e3" id="DDI-DrugBank.d172.s11.p4" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s11.e2" e2="DDI-DrugBank.d172.s11.e3" id="DDI-DrugBank.d172.s11.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s12" text="This response has been attributed to inhibition of renal prostaglandin synthesis."/>
    <sentence id="DDI-DrugBank.d172.s13" text="Aspirin: CELEBREX can be used with low dose aspirin.">
        <entity charOffset="0-6" id="DDI-DrugBank.d172.s13.e0" text="Aspirin" type="brand"/>
        <entity charOffset="9-16" id="DDI-DrugBank.d172.s13.e1" text="CELEBREX" type="brand"/>
        <entity charOffset="44-50" id="DDI-DrugBank.d172.s13.e2" text="aspirin" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s13.e0" e2="DDI-DrugBank.d172.s13.e1" id="DDI-DrugBank.d172.s13.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s13.e0" e2="DDI-DrugBank.d172.s13.e2" id="DDI-DrugBank.d172.s13.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s13.e1" e2="DDI-DrugBank.d172.s13.e2" id="DDI-DrugBank.d172.s13.p2" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s14" text="However, concomitant administration of aspirin with CELEBREX may result in an increased rate of GI ulceration or other complications, compared to use of CELEBREX alone.">
        <entity charOffset="39-45" id="DDI-DrugBank.d172.s14.e0" text="aspirin" type="brand"/>
        <entity charOffset="52-59" id="DDI-DrugBank.d172.s14.e1" text="CELEBREX" type="brand"/>
        <entity charOffset="153-160" id="DDI-DrugBank.d172.s14.e2" text="CELEBREX" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s14.e0" e2="DDI-DrugBank.d172.s14.e1" id="DDI-DrugBank.d172.s14.p0" type="effect"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s14.e0" e2="DDI-DrugBank.d172.s14.e2" id="DDI-DrugBank.d172.s14.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s14.e1" e2="DDI-DrugBank.d172.s14.e2" id="DDI-DrugBank.d172.s14.p2"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s15" text="Because of its lack of platelet effects, CELEBREX is not a substitute for aspirin for cardiovascular prophylaxis.">
        <entity charOffset="41-48" id="DDI-DrugBank.d172.s15.e0" text="CELEBREX" type="brand"/>
        <entity charOffset="74-80" id="DDI-DrugBank.d172.s15.e1" text="aspirin" type="brand"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s15.e0" e2="DDI-DrugBank.d172.s15.e1" id="DDI-DrugBank.d172.s15.p0"/>
    <negationtags>Because of its lack of platelet effects, CELEBREX is &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; a substitute for aspirin for cardiovascular prophylaxis. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d172.s16" text="Fluconazole: Concomitant administration of fluconazole at 200 mg QD resulted in a two-fold increase in celecoxib plasma concentration.">
        <entity charOffset="0-10" id="DDI-DrugBank.d172.s16.e0" text="Fluconazole" type="drug"/>
        <entity charOffset="43-53" id="DDI-DrugBank.d172.s16.e1" text="fluconazole" type="drug"/>
        <entity charOffset="103-111" id="DDI-DrugBank.d172.s16.e2" text="celecoxib" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s16.e0" e2="DDI-DrugBank.d172.s16.e1" id="DDI-DrugBank.d172.s16.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s16.e0" e2="DDI-DrugBank.d172.s16.e2" id="DDI-DrugBank.d172.s16.p1"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s16.e1" e2="DDI-DrugBank.d172.s16.e2" id="DDI-DrugBank.d172.s16.p2" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s17" text="This increase is due to the inhibition of celecoxib metabolism via P450 2C9 by fluconazole (see CLINICAL PHARMACOLOGY - Pharmacokinetics: Metabolism).">
        <entity charOffset="42-50" id="DDI-DrugBank.d172.s17.e0" text="celecoxib" type="drug"/>
        <entity charOffset="79-89" id="DDI-DrugBank.d172.s17.e1" text="fluconazole" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s17.e0" e2="DDI-DrugBank.d172.s17.e1" id="DDI-DrugBank.d172.s17.p0" type="mechanism"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s18" text="CELEBREX should be introduced at the lowest recommended dose in patients receiving fluconazole.">
        <entity charOffset="0-7" id="DDI-DrugBank.d172.s18.e0" text="CELEBREX" type="brand"/>
        <entity charOffset="83-93" id="DDI-DrugBank.d172.s18.e1" text="fluconazole" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s18.e0" e2="DDI-DrugBank.d172.s18.e1" id="DDI-DrugBank.d172.s18.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s19" text="Lithium: In a study conducted in healthy subjects, mean steady-state lithium plasma levels increased approximately 17% in subjects receiving lithium 450 mg BID with CELEBREX 200 mg BID as compared to subjects receiving lithium alone.">
        <entity charOffset="0-6" id="DDI-DrugBank.d172.s19.e0" text="Lithium" type="drug"/>
        <entity charOffset="69-75" id="DDI-DrugBank.d172.s19.e1" text="lithium" type="drug"/>
        <entity charOffset="141-147" id="DDI-DrugBank.d172.s19.e2" text="lithium" type="drug"/>
        <entity charOffset="165-172" id="DDI-DrugBank.d172.s19.e3" text="CELEBREX" type="brand"/>
        <entity charOffset="219-225" id="DDI-DrugBank.d172.s19.e4" text="lithium" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e0" e2="DDI-DrugBank.d172.s19.e1" id="DDI-DrugBank.d172.s19.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e0" e2="DDI-DrugBank.d172.s19.e2" id="DDI-DrugBank.d172.s19.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e0" e2="DDI-DrugBank.d172.s19.e3" id="DDI-DrugBank.d172.s19.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e0" e2="DDI-DrugBank.d172.s19.e4" id="DDI-DrugBank.d172.s19.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e1" e2="DDI-DrugBank.d172.s19.e2" id="DDI-DrugBank.d172.s19.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e1" e2="DDI-DrugBank.d172.s19.e3" id="DDI-DrugBank.d172.s19.p5"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e1" e2="DDI-DrugBank.d172.s19.e4" id="DDI-DrugBank.d172.s19.p6"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s19.e2" e2="DDI-DrugBank.d172.s19.e3" id="DDI-DrugBank.d172.s19.p7" type="mechanism"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e2" e2="DDI-DrugBank.d172.s19.e4" id="DDI-DrugBank.d172.s19.p8"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s19.e3" e2="DDI-DrugBank.d172.s19.e4" id="DDI-DrugBank.d172.s19.p9"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s20" text="Patients on lithium treatment should be closely monitored when CELEBREX is introduced or withdrawn.">
        <entity charOffset="12-18" id="DDI-DrugBank.d172.s20.e0" text="lithium" type="drug"/>
        <entity charOffset="63-70" id="DDI-DrugBank.d172.s20.e1" text="CELEBREX" type="brand"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s20.e0" e2="DDI-DrugBank.d172.s20.e1" id="DDI-DrugBank.d172.s20.p0" type="advise"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s21" text="Methotrexate: In an interaction study of rheumatoid arthritis patients taking methotrexate, CELEBREX did not have a significant effect on the pharmacokinetics of methotrexate.">
        <entity charOffset="0-11" id="DDI-DrugBank.d172.s21.e0" text="Methotrexate" type="drug"/>
        <entity charOffset="78-89" id="DDI-DrugBank.d172.s21.e1" text="methotrexate" type="drug"/>
        <entity charOffset="92-99" id="DDI-DrugBank.d172.s21.e2" text="CELEBREX" type="brand"/>
        <entity charOffset="162-173" id="DDI-DrugBank.d172.s21.e3" text="methotrexate" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s21.e0" e2="DDI-DrugBank.d172.s21.e1" id="DDI-DrugBank.d172.s21.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s21.e0" e2="DDI-DrugBank.d172.s21.e2" id="DDI-DrugBank.d172.s21.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s21.e0" e2="DDI-DrugBank.d172.s21.e3" id="DDI-DrugBank.d172.s21.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s21.e1" e2="DDI-DrugBank.d172.s21.e2" id="DDI-DrugBank.d172.s21.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s21.e1" e2="DDI-DrugBank.d172.s21.e3" id="DDI-DrugBank.d172.s21.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s21.e2" e2="DDI-DrugBank.d172.s21.e3" id="DDI-DrugBank.d172.s21.p5"/>
    <negationtags>Methotrexate: In an interaction study of rheumatoid arthritis patients taking methotrexate, CELEBREX did &lt;scope&gt; &lt;cue&gt; not have &lt;/cue&gt; a significant effect on the pharmacokinetics of methotrexate. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d172.s22" text="Warfarin: The effect of celecoxib on the anti-coagulant effect of warfarin was studied in a group of healthy subjects receiving daily doses of 2-5 mg of warfarin.">
        <entity charOffset="0-7" id="DDI-DrugBank.d172.s22.e0" text="Warfarin" type="drug"/>
        <entity charOffset="24-32" id="DDI-DrugBank.d172.s22.e1" text="celecoxib" type="drug"/>
        <entity charOffset="66-73" id="DDI-DrugBank.d172.s22.e2" text="warfarin" type="drug"/>
        <entity charOffset="153-160" id="DDI-DrugBank.d172.s22.e3" text="warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s22.e0" e2="DDI-DrugBank.d172.s22.e1" id="DDI-DrugBank.d172.s22.p0"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s22.e0" e2="DDI-DrugBank.d172.s22.e2" id="DDI-DrugBank.d172.s22.p1"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s22.e0" e2="DDI-DrugBank.d172.s22.e3" id="DDI-DrugBank.d172.s22.p2"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s22.e1" e2="DDI-DrugBank.d172.s22.e2" id="DDI-DrugBank.d172.s22.p3"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s22.e1" e2="DDI-DrugBank.d172.s22.e3" id="DDI-DrugBank.d172.s22.p4"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s22.e2" e2="DDI-DrugBank.d172.s22.e3" id="DDI-DrugBank.d172.s22.p5"/>
    </sentence>
    <sentence id="DDI-DrugBank.d172.s23" text="In these subjects, celecoxib did not alter the anticoagulant effect of warfarin as determined by prothrombin time.">
        <entity charOffset="19-27" id="DDI-DrugBank.d172.s23.e0" text="celecoxib" type="drug"/>
        <entity charOffset="71-78" id="DDI-DrugBank.d172.s23.e1" text="warfarin" type="drug"/>
        <pair ddi="false" e1="DDI-DrugBank.d172.s23.e0" e2="DDI-DrugBank.d172.s23.e1" id="DDI-DrugBank.d172.s23.p0"/>
    <negationtags>In these subjects, celecoxib did &lt;scope&gt; &lt;cue&gt; not &lt;/cue&gt; alter the anticoagulant effect of warfarin as determined by prothrombin time. &lt;/scope&gt;</negationtags></sentence>
    <sentence id="DDI-DrugBank.d172.s24" text="However, caution should be used when administering CELEBREX with warfarin since these patients are at increased risk of bleeding complications.">
        <entity charOffset="51-58" id="DDI-DrugBank.d172.s24.e0" text="CELEBREX" type="brand"/>
        <entity charOffset="65-72" id="DDI-DrugBank.d172.s24.e1" text="warfarin" type="drug"/>
        <pair ddi="true" e1="DDI-DrugBank.d172.s24.e0" e2="DDI-DrugBank.d172.s24.e1" id="DDI-DrugBank.d172.s24.p0" type="advise"/>
    </sentence>
</document>